About IDT Biologika
IDT Biologika is a company based in Dessau-roßlau (Germany) founded in 1921 was acquired by SK bioscience in June 2024.. IDT Biologika has completed 2 acquisitions, including Gallant Custom Laboratories and Ridgeway Biologicals. IDT Biologika offers products and services including Vaccine Manufacturing, Cell and Gene Services, and Sterile Injectables. IDT Biologika operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Dessau-roßlau, Germany
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Idt Biologika Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Deutsche Bank
& 7 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Gallant Custom Laboratories
& 1 more
-
Acquired by
SK bioscience
(Jun 27, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IDT Biologika
IDT Biologika offers a comprehensive portfolio of products and services, including Vaccine Manufacturing, Cell and Gene Services, and Sterile Injectables. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Development and production of viral vaccines for clinical and commercial use.
Production of gene and immune therapeutics using advanced viral vectors.
Aseptic fill-finish and lyophilization for sterile pharmaceutical products.
Unlock access to complete
Funding Insights of IDT Biologika
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(06 Feb 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Grant - IDT Biologika | Valuation |
investors |
|
| Aug, 2017 | Amount | Grant - IDT Biologika | Valuation |
investors |
|
| Sep, 2016 | Amount | Grant - IDT Biologika | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IDT Biologika
IDT Biologika has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Deutsche Bank, UniCredit and Commerzbank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are targeted by this private equity firm.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Diversified banking and financial services are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IDT Biologika
IDT Biologika has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Gallant Custom Laboratories and Ridgeway Biologicals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufactures and supplies autogenous vaccines
|
1999 | ||||
|
Autogenous biologics for animal health and disease treatment are manufactured.
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - IDT Biologika
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Idt Biologika Comparisons
Competitors of IDT Biologika
IDT Biologika operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| domain | founded_year | HQ Location |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Precision fermentation services for biopharma and food are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Idt Biologika
Frequently Asked Questions about IDT Biologika
When was IDT Biologika founded?
IDT Biologika was founded in 1921 and raised its 1st funding round 95 years after it was founded.
Where is IDT Biologika located?
IDT Biologika is headquartered in Dessau-roßlau, Germany. It is registered at Dessau-roßlau, Sachsen-anhalt, Germany.
Who is the current CEO of IDT Biologika?
Andreas Kastenbauer is the current CEO of IDT Biologika.
What does IDT Biologika do?
IDT Biologika was founded in 1921 as a CDMO focused on biologics. Development and manufacturing services for vaccines up to BSL 2, ADCs, monoclonal antibodies, therapeutic proteins, and other agents are provided. Large-scale production occurs in dosage forms including lyophilized vials, pre-filled syringes, and devices like injectors. Facilities in Germany and the USA are approved by EMA and FDA. Collaborations with partners such as CMC Biologics support integrated ADC solutions.
Who are the top competitors of IDT Biologika?
IDT Biologika's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does IDT Biologika offer?
IDT Biologika offers Vaccine Manufacturing, Cell and Gene Services, and Sterile Injectables.
How many acquisitions has IDT Biologika made?
IDT Biologika has made 2 acquisitions, including Gallant Custom Laboratories, and Ridgeway Biologicals.
Who are IDT Biologika's investors?
IDT Biologika has 8 investors. Key investors include Deutsche Bank, UniCredit, Commerzbank, European Union, and CEPI.